United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

merck sharp & dohme (uk) ltd - varicella-zoster virus live attenuated (oka/merck strain) - powder and solvent for suspension for injection

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

merck sharp & dohme ltd - varicella-zoster virus live attenuated (oka/merck strain) - powder and solvent for suspension for injection

Malta - English - Medicines Authority

merck healthcare kgaa frankfurter strasse 250, 64293 darmstadt, germany - vildagliptin - tablet - vildagliptin 50 mg - drugs used in diabetes

New Zealand - English - Medsafe (Medicines Safety Authority)

fresenius kabi new zealand limited - chromium trichloride hexahydrate 5.33 µg/ml;  ; copper chloride dihydrate 0.34 mg/ml;  ; ferric chloride hexahydrate 0.54 mg/ml;  ; manganese chloride tetrahydrate 99 µg/ml;  ; potassium iodide 16.6 µg/ml; sodium fluoride 0.21 mg/ml; sodium molybdate dihydrate 4.85 µg/ml;  ; sodium selenite 10.5 µg/ml;  ;  ; zinc chloride 1.36 mg/ml;  ;  ; chromium trichloride hexahydrate 5.33 µg/ml; copper chloride dihydrate 102.3 µg/ml; ferric chloride hexahydrate 540 µg/ml; manganese chloride tetrahydrate 19.79 µg/ml; potassium iodide 16.6 µg/ml; sodium fluoride 210 µg/ml; sodium molybdate dihydrate 4.85 µg/ml; sodium selenite 17.29 µg/ml; zinc chloride 1050 µg/ml - solution for infusion - active: chromium trichloride hexahydrate 5.33 µg/ml   copper chloride dihydrate 0.34 mg/ml   ferric chloride hexahydrate 0.54 mg/ml   manganese chloride tetrahydrate 99 µg/ml   potassium iodide 16.6 µg/ml sodium fluoride 0.21 mg/ml sodium molybdate dihydrate 4.85 µg/ml   sodium selenite 10.5 µg/ml     zinc chloride 1.36 mg/ml     excipient: hydrochloric acid water for injection xylitol active: chromium trichloride hexahydrate 5.33 µg/ml copper chloride dihydrate 102.3 µg/ml ferric chloride hexahydrate 540 µg/ml manganese chloride tetrahydrate 19.79 µg/ml potassium iodide 16.6 µg/ml sodium fluoride 210 µg/ml sodium molybdate dihydrate 4.85 µg/ml sodium selenite 17.29 µg/ml zinc chloride 1050 µg/ml excipient: hydrochloric acid water for injection xylitol - to meet basal to moderately increased requirements of trace elements in parenteral nutrition in adults and children weighing 15 kg and over, when either oral or enteral nutrition is inappropriate

New Zealand - English - Medsafe (Medicines Safety Authority)

merck sharp & dohme (new zealand) limited - cefoxitin sodium 1.18 g equivalent to cefoxitin 1.1 g (includes overage) - powder for injection - 1 g - active: cefoxitin sodium 1.18 g equivalent to cefoxitin 1.1 g (includes overage)

New Zealand - English - Medsafe (Medicines Safety Authority)

merck sharp & dohme (new zealand) limited - pneumococcal polysaccharide vaccine 50 µg/ml (25mcg/dose of each of 23 named pneumococcal polysaccharides) - solution for injection - active: pneumococcal polysaccharide vaccine 50 µg/ml (25mcg/dose of each of 23 named pneumococcal polysaccharides) excipient: phenol sodium chloride water for injection - pneumovax 23 is indicated for vaccination against pneumococcal disease caused by those pneumococcal types included in the vaccine.

New Zealand - English - Medsafe (Medicines Safety Authority)

merck sharp & dohme (new zealand) limited - cilastatin sodium 571mg equivalent to to 500 mg cilastatin acid. includes 4.6% overage.; imipenem monohydrate 560mg equivalent to to 500 mg imipenem. includes 4.6% overage. - powder for injection - active: cilastatin sodium 571mg equivalent to to 500 mg cilastatin acid. includes 4.6% overage. imipenem monohydrate 560mg equivalent to to 500 mg imipenem. includes 4.6% overage. excipient: sodium bicarbonate

Israel - English - Ministry of Health

merck sharp & dohme israel ltd - aprepitant - capsules - aprepitant 80 mg - aprepitant - aprepitant - emend in combination with other antiemetic agents is indicated for the: - prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy including high-dose cisplatin. - prevention of nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy.

Israel - English - Ministry of Health

merck sharp & dohme israel ltd - aprepitant - capsules - aprepitant 80 mg - aprepitant - aprepitant - emend in combination with other antiemetic agents is indicated for the: - prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy including high-dose cisplatin. - prevention of nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy.

Israel - English - Ministry of Health

merck sharp & dohme (israel - 1996) company ltd, israel - aprepitant - capsules - aprepitant 80 mg - aprepitant - aprepitant - emend in combination with other antiemetic agents is indicated for the: - prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy including high-dose cisplatin. - prevention of nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy.